Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed ...

The National Psoriasis Foundation raised more than $1.5 million during its annual Commit to Cure gala, breaking previous fundraising records and furthering ongoing efforts to find a cure for psoriatic ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April ...

The dermatology market in the U.S. is at a pivotal moment of transformation, with spending poised to climb from $40.55 billion in 2023 to $70 billion by 2030. This unprecedented growth mirrors past ...

If you take other medications, it’s important to make sure it’s safe to take them alongside ibuprofen as the last thing you ...